Erwan Martin
Nessuna posizione attualmente
Profilo
Erwan Martin was the founder and had founded Cytomics Pharmaceuticals SA in 2000, where he held the title of Finance Director from 2009 to 2011.
He has also worked as a Director at Nexess SA and as the Chief Financial & Administrative Officer at Génomic Vision SA. Mr. Martin was the Chief Financial Officer at Cellnovo Group SA from 2017 to 2019.
He also worked as an Analyst at Syndex Corp.
Mr. Martin holds an MBA from Warwick Business School and an undergraduate degree from Ecole Supérieure de Commerce de Toulouse.
Precedenti posizioni note di Erwan Martin
| Società | Posizione | Fine |
|---|---|---|
| CELLNOVO | Direttore Finanziario/CFO | 01/08/2019 |
Cytomics Pharmaceuticals SA
 Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Fondatore | 10/10/2011 |
Nexess SA
 Nexess SA Miscellaneous Commercial ServicesCommercial Services Nexess SA provides safety and security solutions. The firm specializes in tags, software, traceability, metrology, tools management, sensitive products, aeronautic, aerospace, nuclear energy, security, harsh environment, smart cabinet, and connected objects. The company was founded by Frederic Galtier in 2008 and is headquartered in Mougins, France. | Direttore/Membro del Consiglio | - |
Syndex Corp.
 Syndex Corp. Food DistributorsDistribution Services Syndex Corp. is a private company that wholesales fruits and vegetables. The company is based in Houston, TX and has subsidiaries in United States. | Corporate Officer/Principal | - |
| GENOMIC VISION | Direttore Finanziario/CFO | - |
Formazione di Erwan Martin
| Ecole Supérieure de Commerce de Toulouse | Undergraduate Degree |
| Warwick Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENOMIC VISION | Health Technology |
| Aziende private | 4 |
|---|---|
Cytomics Pharmaceuticals SA
Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Health Technology |
Syndex Corp.
Syndex Corp. Food DistributorsDistribution Services Syndex Corp. is a private company that wholesales fruits and vegetables. The company is based in Houston, TX and has subsidiaries in United States. | Distribution Services |
Nexess SA
Nexess SA Miscellaneous Commercial ServicesCommercial Services Nexess SA provides safety and security solutions. The firm specializes in tags, software, traceability, metrology, tools management, sensitive products, aeronautic, aerospace, nuclear energy, security, harsh environment, smart cabinet, and connected objects. The company was founded by Frederic Galtier in 2008 and is headquartered in Mougins, France. | Commercial Services |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Cellnovo Group SA was a medical technology company, which specialized in diabetes. The company developed and marketed the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. It products portfolio included system, switch, pump therapy, and patient stories. The company was founded by Julian Shapley on December 15, 2014 and was headquartered in Paris, France. | Health Technology |
- Borsa valori
- Insiders
- Erwan Martin
